Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 3 of 100
Finance
AstraZeneca CEO hopes U.S. will represent half of company’s global revenue by 2030—vows to invest and expand in nation despite tariff threat
By
Market Analyst
April 29, 2025
Health
Pharma giant Merck expects Trump’s tariffs to cost the company $200 million
By
Maia Anderson
and
Healthcare Brew
April 25, 2025
Health
Swiss drugmaker Roche leans into Trump tariff formula with $50 billion promise to invest in U.S.
By
Senior Editor
April 22, 2025
Retail
Novo Nordisk slides on pressure from Lilly’s pill study
By
Marthe Fourcade
and
Bloomberg
April 22, 2025
Politics
Trump eyes new tariffs on semiconductors and pharmaceuticals as U.S. only makes 20% of world’s drugs and 0% of advanced logic chips
By
Elaine Kurtenbach
and
The Associated Press
April 15, 2025
Health
Europe’s pharma titans confront von der Leyen with threat to yank $113 billion from EU and relocate to U.S. as Trump plans ‘major’ tariffs
By
News Correspondent
April 9, 2025
Finance
Could Trump tariffs solve Ireland’s housing crisis?
By
Editorial Team
April 8, 2025
Newsletters
How Trump’s import tariffs shocked tech stocks
By
Senior Editor
April 4, 2025
Retail
Siemens to boost drug discoveries using AI through the $5.1 billion acquisition of U.S. software firm Dotmatics
By
Senior Editor
April 3, 2025
Features
Will AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market
By
News Correspondent
April 3, 2025
Leadership
GSK employees perform anonymous ‘180’ surveys on their bosses, and CEO Emma Walmsley isn’t exempt
By
Blockchain Reporter
April 2, 2025
Health
Mark Cuban warns Trump’s tariffs mean his Cost Plus Drugs ‘won’t have a choice’ but to raise prices for consumers
By
Senior Editor
April 1, 2025
Tech
As a kid, she raised money to cure cystic fibrosis. Now she’s the CEO of a $2.6 billion genetic testing company
By
Staff Writer
March 31, 2025
Finance
Vietnam seizes 1.4 tons of ketamine as police bust country’s biggest synthetic drug factory
By
Trading Desk
March 27, 2025
Tech
Sanofi’s chief digital officer says remote work means employees lose the ‘serendipity’ needed to innovate
By
Digital Assets Editor
March 27, 2025
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Market Analyst
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
Investment Desk
Big Tech
Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
By
Market Analyst